Zobrazeno 1 - 10
of 726
pro vyhledávání: '"M, Lise"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of Laryngology & Otology. 127:1235-1237
Background:The tensor tympani muscle is the largest muscle within the middle ear. Its voluntary contraction is a very unusual event. Only a few papers have documented its audiometric effects.Objective:To report an unusual case of voluntary tensor tym
Autor:
M, Agostini, S, Pulciarelli, S, Pucciarelli, R, Bertorelle, P, Calandra, F, Villani, M, Lise, D, Nitti
Publikováno v:
Scopus-Elsevier
Purpose To analyze the genetic variability in a variable number of tandem repeats (VNTR) in the thymidylate synthase (TS) enhancer promoter region and assess the influence of functional alterations in mismatch repair genes by analyzing constitutional
Publikováno v:
Techniques in Coloproctology. 3:63-66
The purpose of our study was to ascertain whether Sarafoff's anoplasty is a valid option for anal ectropion (eversion), in which mucosal prolapse causes continuous mucus discharge and faecal incontinence from loss of sensitivity due to anal skin remo
Autor:
G Semenzato, Carlo Agostini, Pietro Bulian, Andrea Cerutti, Livio Trentin, C Enthammer, M Lise, Renato Zambello, Donato Nitti, Marco A. Cassatella
Publikováno v:
British Journal of Cancer
Tumour necrosis factor alpha (TNF-alpha) is a cytokine with a variety of immunological properties. The identification of two receptors for this molecule, i.e. the 75 kDa and the 55 kDa TNF receptors (TNF-R), recently clarified the mechanisms through
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
Autor:
G M, Clifford, M, Lise, S, Franceschi, M, Egger, C, Bouchardy, D, Korol, F, Levi, S, Ess, G, Jundt, G, Wandeler, J, Fehr, P, Schmid, M, Battegay, E, Bernasconi, M, Cavassini, A, Calmy, O, Keiser, F, Schöni-Affolter, S, Yerly
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Vol. 106, No 3 (2012) pp. 447-52
Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F; Swiss HIV Cohort Study, (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British journal of cancer, 106(3), pp. 447-452. Basingstoke: Nature Publishing Group 10.1038/bjc.2011.558
British journal of cancer
British Journal of Cancer, Vol. 106, No 3 (2012) pp. 447-52
Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F; Swiss HIV Cohort Study, (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British journal of cancer, 106(3), pp. 447-452. Basingstoke: Nature Publishing Group 10.1038/bjc.2011.558
British journal of cancer
Background:Immunodeficiency and AIDS related pulmonary infections have been suggested as independent causes of lung cancer among HIV infected persons in addition to smoking.Methods:A total of 68 lung cancers were identified in the Swiss HIV Cohort St
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063dedf64643bda77a8233b6c48a0bb1
https://doi.org/10.5167/uzh-69145
https://doi.org/10.5167/uzh-69145
Publikováno v:
Digestive Surgery. 11:111-117
We here briefly review the most important clinical trials on adjuvant chemotherapy for gastric cancer published since the 60s and present the results of study No. 40813 of the European Organization fo
Autor:
S, Franceschi, M, Lise, G M, Clifford, M, Rickenbach, F, Levi, M, Maspoli, C, Bouchardy, S, Dehler, G, Jundt, S, Ess, A, Bordoni, I, Konzelmann, H, Frick, L, Dal Maso, L, Elzi, H, Furrer, A, Calmy, M, Cavassini, B, Ledergerber, O, Keiser, S, Yerly
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Vol. 103, No 3 (2010) pp. 416-422
Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B and Keiser, O (2010). Changing patterns of cancer incidence in the early-and late-HAART periods: the Swiss HIV Cohort Study. British journal of cancer, 103(3), pp. 416-422. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6605756
British Journal of Cancer, vol. 103, no. 3, pp. 416-422
British Journal of Cancer, Vol. 103, No 3 (2010) pp. 416-422
Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B and Keiser, O (2010). Changing patterns of cancer incidence in the early-and late-HAART periods: the Swiss HIV Cohort Study. British journal of cancer, 103(3), pp. 416-422. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6605756
British Journal of Cancer, vol. 103, no. 3, pp. 416-422
BACKGROUND: The advent of highly active antiretroviral therapy (HAART) in 1996 led to a decrease in the incidence of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), but not of other cancers, among people with HIV or AIDS (PWHA). It also led t
Publikováno v:
American journal of health behavior. 32(1)
To examine how stress and health-related behaviors affect freshman weight change by gender.Three hundred ninety-six freshmen completed a 40-item health behavior survey and height and weight were collected at baseline and follow-up.Average weight chan
Autor:
C R, Rossi, M, Foletto, S, Mocellin, P L, Pilati, L, Campana, D, Rubello, D, Ribello, M, Lise
Publikováno v:
Journal of experimentalclinical cancer research : CR. 22
Isolated limb perfusion (ILP) is currently considered the standard treatment for melanoma patients with extensive in-transit disease, and L-PAM, combined or not with TNF, represents the most active drug. We here report on our clinical experience with